Michael Moritz, M.D.

  • Professor of Pediatrics 
  • Clinical Director, Division of Nephrology
  • Medical Director, Pediatric Dialysis

Major Lectureships and Seminars

  • Three Rivers Chapter of National Association of Pediatric Nurse Practitioners (NAPNAP). “Outpatient Pediatric Nephrology”. Pittsburgh, PA, December 7, 2016
  • American Nephrology Nurses Association (ANNA) Spring Ahead meeting. “What Nurses Need to Know About Hyponatremia”. Pittsburgh, PA, May 21, 2017
  • Pediatric Grand Rounds: “Prevention and Treatment of Hospital-acquired Hyponatremia”. Loma Linda University Health, Loma Linda CA, June 16, 2017
  • Pediatric Grand Rounds: “Prevention and Treatment of Hospital-acquired Hyponatremia”. NYU School of Medicine, New York, NY, June 20, 2017

Professional Affiliations/Society Memberships

  • American Academy of Pediatrics
  • American Society of Nephrology
  • American Society of Pediatric Nephrology
  • International Pediatric Nephrology Association
  • National Kidney Foundation
  • Society for Pediatric Research

Education & Training

  • MD: University of Chicago, Pritzker School of Medicine Chicago, IL
  • Residency: University of Chicago, Pritzker School of Medicine Chicago, IL
  • Fellowships: Baylor College of Medicine Houston, TX

Research Interests

Michael Moritz focused on the epidemiology and treatment of dysnatremias in children. He introduced the concept of using 0.9% sodium chloride in maintenance parenteral fluids for the prevention of hospital-acquired hyponatremia, and he has been an outspoken advocate for this therapy. This has resulted in a worldwide change in medical practice in both children and adults. He also introduced the concept of using intermittent 3% sodium chloride boluses for the treatment of hyponatremic encephalopathy, and this is now being accepted as the treatment of choice by consensus guidelines. He is an internationally recognized expert in the controversial topic of salt poisoning in children and has served as a medical expert in high-profile trials in the United Kingdom and United States. He also has conducted seminal work in the epidemiology and prevention of breastfeeding-associated hypernatremia. He was the first to report on bleeding complications from high-concentration heparin to pack hemodialysis catheters in children. He is clinical director of the Division of Nephrology and the medical director of Children’s Hospital of Pittsburgh’s Pediatric Dialysis Unit. His specific research interests included disorders in sodium and water metabolism (central pontine myelinolysis, hyponatremic encephalopathy, hypernatremic dehydration, salt poisoning, fluid therapy), hemodialysis access in children, and pediatric hypertension trials. Moritz is also the chief editor of Frontiers in Pediatrics. In that capacity, he oversees 20 journal sections and almost 3,000 editorial board members. In 2016, he was selected for the Chief Editor’s Award out of a field of 54 chief editors.